New Zealand markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
262.13+3.16 (+1.22%)
At close: 04:00PM EDT
264.81 +2.68 (+1.02%)
After hours: 06:21PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,129,409
4,129,409
3,976,060
3,540,160
2,923,933
Cost of revenue
2,626,853
2,626,853
2,513,409
2,205,522
1,850,392
Gross profit
1,502,556
1,502,556
1,462,651
1,334,638
1,073,541
Operating expenses
Selling general and administrative
747,855
747,855
665,098
619,919
528,935
Total operating expenses
885,295
885,295
811,676
744,776
640,812
Operating income or loss
617,261
617,261
650,975
589,862
432,729
Interest expense
136,710
136,710
59,291
73,910
86,433
Total other income/expenses net
95,537
95,537
30,523
-35,894
99,984
Income before tax
581,284
581,284
622,987
480,710
447,114
Income tax expense
100,914
100,914
130,379
81,873
81,808
Income from continuing operations
480,370
480,370
492,608
398,837
365,306
Net income
474,624
474,624
486,226
390,982
364,304
Net income available to common shareholders
474,624
474,624
486,226
390,982
364,304
Basic EPS
9.31
-
9.57
7.77
7.35
Diluted EPS
9.23
-
9.48
7.60
7.20
Basic average shares
51,128
-
50,812
50,293
49,550
Diluted average shares
51,457
-
51,301
51,425
50,611